Please try another search
Hualan Biological Bacterin Inc. engages in the research, development, production, and sale of vaccines in China. It offers influenza virus split vaccines, quadrivalent influenza virus split vaccines, H1N1 influenza virus split vaccines, ACYW135 meningococcal polysaccharide plague vaccines, recombinant hepatitis B vaccines, and group A and C meningococcal polysaccharide vaccines, as well as genetic engineering vaccines for human use. The company was founded in 2005 and is based in Xinxiang, China.
Name | Age | Since | Title |
---|---|---|---|
Chaoyuan Ma | 39 | 2020 | Non-Employee Supervisor |
Dexin Li | 70 | 2020 | Independent Director |
Guanmu Dong | 71 | 2020 | Independent Director |
Yuancheng Lou | 39 | 2020 | Supervisory Board Chairman |
Yang Dong Sheng | 59 | 2020 | Independent Director |
Xiaowei Ma | 55 | 2020 | Non-Independent Director |
Kang An | 74 | 2020 | Non-Independent Chairman |
Bei Fan | 51 | 2020 | Non-Independent Director |
Wenqi An | 44 | 2020 | Non-Independent Director |
Wenjue An | 34 | 2022 | GM & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review